Rare Neoplasm — Trials

Rare Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–31 of 31 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07529808	Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma	recruiting	Phase 1 / Phase 2	164	BigHat Biosciences, Inc.INDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT04044859	ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)	active not recruiting	Phase 1	120	USWM CT, LLCINDUSTRY	3	Sep 23, 2026	clinicaltrials